(Q46533530)

22 December 2017

title

Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder (English)

1 reference

22 December 2017

0 references

1 reference

T Eller

1

1 reference

22 December 2017

V Vasar

series ordinal

2

1 reference

22 December 2017

J Shlik

series ordinal

3

1 reference

22 December 2017

E Maron

series ordinal

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

18 June 2008

1 reference

22 December 2017

Journal of Psychopharmacology

published in

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

854-858

1 reference

22 December 2017

Bupropion for fatigue and as a tumor necrosis factor-alpha lowering agent in primary biliary cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

IL-6 levels decrease with SSRI treatment in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Effects of antidepressants on the production of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Cytokines and the brain: implications for clinical psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Cytokine profiles in women with different subtypes of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Th1, Th2, and Th3 cytokine alterations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

Use of bupropion in combination with serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091077

21 January 2018

Identifiers

DOI

10.1177/0269881108091077

1 reference

22 December 2017

1 reference

22 December 2017